SUBSTITUTED BENZIMIDAZOL-2-ONES AS VASOPRESSIN RECEPTOR ANTAGONISTS AND NEUROPEPTIDE Y MODULATORS
申请人:Ortho-McNeil Pharmaceutical, Inc.
公开号:EP1330451B1
公开(公告)日:2008-01-23
HETEROARYL SUBSTITUTED TETRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5
申请人:Merck & Co., Inc.
公开号:EP1434773A2
公开(公告)日:2004-07-07
EP1434773A4
申请人:——
公开号:EP1434773A4
公开(公告)日:2005-01-12
US7253190B2
申请人:——
公开号:US7253190B2
公开(公告)日:2007-08-07
[EN] HETEROARYL SUBSTITUTED TETRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5<br/>[FR] COMPOSES DE TETRAZOLE SUBSTITUES PAR HETEROARYLE, MODULATEURS DU RECEPTEUR-5 METABOTROPIQUE DU GLUTAMATE
申请人:MERCK & CO INC
公开号:WO2003029210A2
公开(公告)日:2003-04-10
Tetrazole compounds substituted directly, or by a bridge, with a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, and panic, as well as in the treatment of pain and other diseases.